Synoptic Bio — Talent Pipeline
Q2 2026 · Biweekly Search Cadence · 19 Roles · 34 Candidates
Updated Q2 2026 ← Data Room
34
Total Candidates
1
Hired
5
Ready to Hire
1
Active Interest
3
In Conversation
22
Not Approached
1
CRO / Partner
11
SAB Candidates
1
SAB Confirmed
Seed — Core Team Hiring now · 4 roles · Click any card to see full details
Founding CEO
Seed Stage
1 identified
✓ Hired
Chris Whelan — Role Filled
Focus efforts on CMO, Chief Technology Officer, and PM hires.
View full profile & context ↗
Chief Technology Officer
Seed Stage
1 identified
Ready to Hire
Sara Ahadi, PhD — lead candidate; ready to start, incorporation pending.
Complete incorporation so Sara Ahadi can formally start as CTO lead.
View full details & 1 candidate ↗
Principal Scientist, Computational Biology
Seed Stage
4 identified
Initial conversation
Daniel McCartney, PhD — contracted 0.5 FTE Principal Scientist (bioXcelerate / Optima Partners). Jacqueline Dron (Broad Institute) in pipeline.
Daniel McCartney contracted and active. Open conversation with Jacqueline Dron (Broad) re: DS#1 fit. Assess Abolfazl Doostparast seniority before approach.
View full details & 4 candidates ↗
Scientist, Computational Proteomics
Seed Stage
3 identified
CRO Contracted
Douglas Y. Kirsher, M.S. — lead FTE candidate; initial conversation via Sara Ahadi.
Progress Douglas Kirsher conversation via Sara Ahadi. Align on workstream scope (at-home collection validation + Olink/Nomic benchmarking).
View full details & 3 candidates ↗
Seed — Expanded Team 8 roles · priority scales with raise amount · fractional advisors active now
Senior Project & Operations Manager
Seed / Series A
2 identified
Ready to Hire
Trish Vosburg (formerly Broad Institute) — very interested
Align on working-hours expectations before offer. Boston location is a structural asset for Broad Clinical Labs & EPIC consortium coordination.
View full details & 2 candidates ↗
Data / Platform Engineer
Seed / Series A
Open search
Not Approached
Open search — biotech / health-tech data engineering; proteomics or genomics data pipeline experience preferred
Priority at $5–6M raise. Begin sourcing once CTO start date is confirmed. AWS/GCP-native; HIPAA-compliant architecture essential.
View full details ↗
Fractional CFO
Seed Stage
Open search
Not Approached
Open search — ex-GRAIL / SomaLogic / Exact Sciences diagnostics finance alumni; NIH grant accounting experience
Prioritise at $5–6M raise; essential for NIH SBIR/STTR grant compliance and Series A preparation. Engage via MassBio / BioNJ fractional CFO networks.
View full details ↗
Director of Regulatory Affairs (Fractional)
Seed Stage
1 identified
Ready to Hire
Erika Lokander — confirmed; fractional Sr Director RA, scope for full-time post-seed.
Proceed with onboarding. Align on fractional scope, hours, and comp. Introduce to CMO lead once engagement progresses.
View full details & 1 candidate ↗
Government Affairs & Federal Funding (Fractional)
Seed Stage
1 identified
Ready to Hire
Lara Lee Hullinghorst — confirmed; 25+ yrs federal appropriations; architect of first proteomics DoD & NIH LHHS call-outs.
Align on fractional scope and engagement terms. Brief on NIH and ARPA-H funding targets; coordinate on French government follow-up (Paris, May/Jun 2026).
View full details & 1 candidate ↗
Clinical Laboratory & Diagnostics (Fractional)
Seed Stage
1 identified
Initial conversation
Niall J. Lennon, PhD — CSO & Chair, Broad Clinical Laboratories; in discussions; BCL is Synoptic's designated CLIA/CAP lab partner for the proteomics platform (SYN-WAVE & SYN-DROME).
Progress conversation on advisory scope. Align on BCL as CLIA/CAP lab partner for Synoptic's proteomics platform; discuss CLIA validation pathway for SYN-WAVE organ aging panels.
View full details & 1 candidate ↗
Clinical Research Coordinator
Seed Stage
Open search
Not Approached
Open search — oncology diagnostics or LDT study coordination; IRB submission experience; Boston / Cambridge location preferred
Begin search once SYN-WAVE clinical validation protocol is locked. Boston/Cambridge location strongly preferred given Broad Clinical Labs partnership.
View full details ↗
Chief Business Officer
Seed / Series A
2 identified
Active Interest
Evan Mills (Thermo Fisher / Olink VP Global Sales) — interested, evaluating
Allow time for Evan to evaluate salary & career-risk trade-off; prepare comp structure and equity narrative.
View full details & 2 candidates ↗
Series A 7 roles · begin targeted mapping now · hire post-Series A close
CMO / VP Clinical & Regulatory
Series A
8 identified
Initial Conversation
David Morgenstern, PhD (DELFI Diagnostics — lead candidate, intro via Karl Smith-Byrne); DeAunne Denmark in pipeline for CMO discussion; David Perlman as potential Translational / Medical lead
Progress David Morgenstern conversation via Karl intro. Open CMO-role conversation with DeAunne Denmark. Evaluate David Perlman for Translational / Medical lead scope. Pair with Lokander (regulatory) on reimbursement strategy.
View full details & 8 candidates ↗
Expanded Data Sciences Team
Seed / Series A
2 identified
Not Approached
Shirley Nieves-Rodriguez, PhD (J&J) — designated FTE lead
Approach after Liping Hou outreach is underway.
View full details & 2 candidates ↗
Director of Medical Affairs
Series A
Open search
Not Approached
Open search — GRAIL / Guardant / Foundation Medicine medical affairs alumni; KOL engagement and publication strategy experience; MD or PhD preferred
Begin building target list from GRAIL and Guardant medical affairs alumni. Do not approach until CMO is in place and can lead this hire.
View full details ↗
VP Product & DTC Platform
Series A
Open search
Not Approached
Open search — consumer health or DTC genomics/diagnostics product leadership; Color / Function Health / Levels Health / DTC genomics alumni
Begin scoping once DTC go-to-market strategy is defined post-Series A. DTC genomics and consumer health alumni are natural targets.
View full details ↗
VP Marketing & Scientific Communications
Series A
Open search
Not Approached
Open search — diagnostics or consumer health marketing; scientific credibility with clinical audience; GRAIL / Exact Sciences / DTC diagnostics alumni
Source from GRAIL and Exact Sciences marketing alumni post-Series A. Pair with CBO on commercial go-to-market architecture before making this hire.
View full details ↗
Head of People & Culture
Series A
Open search
Not Approached
Open search — early-stage biotech people ops; team scale 10–50; Radford / J.Thelander compensation benchmarking experience
Fractional HR at seed (TriNet or Sequoia One). Transition to FTE Head of People at Series A when headcount approaches 12–15.
View full details ↗
General Counsel (Fractional → FTE)
Series A
Open search
Not Approached
Open search — biotech IP and corporate counsel; proteomics assay and bioinformatics method patent strategy; Wilson Sonsini / Cooley / Foley Hoag alumni
Outside IP counsel at seed (Wilson Sonsini or Foley Hoag). Fractional GC or in-house from Series A close. Begin GC search at term sheet stage.
View full details ↗
All Candidates 34 records · Click column headers to sort · Click rows to expand
Priority ▲▼ Stage ▲▼ Role ▲▼ Name ▲▼ Current Title / Organization Exp. ▲▼ Status ▲▼ Location ▲▼ LinkedIn
🔬 Scientific Advisory Board 4 advisory categories · 11 candidates · 1 confirmed
1 Confirmed
1 Warm / Stay in Touch
8 Not Approached
2 Flags / Cautions
Filter:
document.getElementById('last-updated').textContent = new Date(document.lastModified).toLocaleDateString('en-GB', { day: 'numeric', month: 'short', year: 'numeric' });